NCT03691389 is a clinical trial in Observation, sponsored by Yale-NUS College.

Who is sponsoring NCT03691389?

NCT03691389 is sponsored by Yale-NUS College.

What condition does NCT03691389 study?

NCT03691389 studies Observation.

Is NCT03691389 still recruiting?

NCT03691389 is currently status unknown. Last updated 22 January 2019.

Last reviewed 2019-01-22 · How we verify

NCT03691389

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigating the Relationship Between Parents and Their Children With ADHD and Conduct Disorder

Status unknown Last updated 22 January 2019

What this trial tests

trial in Observation in 20 participants. Status unknown.

Timeline

1 February 2019

Primary endpoint
31 March 2019

31 March 2019

Quick facts

Lead sponsor	Yale-NUS College
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 February 2019
Primary completion	31 March 2019
Estimated completion	31 March 2019

Conditions studied

Observation — all drugs for Observation →

Sponsor

Yale-NUS College

Who can join

Eligibility, any sex, with Observation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to uncover mechanisms of action underlying any long-term change in youth antisocial behavior by considering the role of child and family characteristics as mediators and moderators of change. The study design is qualitative interviews to be conducted face-to-face with parents of children previously diagnosed with Conduct Disorder and Attention Deficit Hyperactivity Disorder (ADHD) but no longer meet diagnostic criteria. Questions will be asked to understand participants' parenting experience over time (before, during and after their children's treatment).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Yale-NUS College trials

Trials by the same sponsor.

NCT06440785 — Taylor Swift and Mental Health Outcomes · recruiting
NCT06440798 — Mental Health Content and Mental Health Outcomes · recruiting
NCT04967846 — Social Media Effects on Mental Health · completed
NCT04918849 — WhatsApp in India During the COVID-19 Pandemic · unknown
NCT04448704 — Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03691389 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale-NUS College
Last refreshed: 22 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03691389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing